Long Acting Insulin is Safer & More Effective for People with Type 1 Diabetes

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with Type 1 diabetes, according to new research published in the BMJ.  Researchers looked at once-daily and twice-daily doses of both long- and intermediate-acting insulin, ranking their effectiveness, safety and cost-effectiveness. “In patients with Type 1 diabetes, we found that long-acting insulin is…

Read More

Patent, Brand and Generic Named Drugs: Confused?

I have noticed in recent times that there is a lot of confusion amongst patients in regards to the names of their medications. Having done some investigation into this, it appears to be around certain medications that have come off of patent and the pharmacy is now dispensing the cheaper equivalent but under a different name…

Read More

90 Years of Insulin: The Story Of Elizabeth Hughes

On the 23rd of January 2012, marked the 90th anniversary of the first person with Type 1 Diabetes in the world being treated with insulin, a 14 year old boy called Leonard Thompson. It reminded me of a book that has recently come on the market to commerate the 90th anniversary of the discovery of insulin called…

Read More
an Insulin pen from Diabetes Insight, Cork, Ireland

Have you heard of Biosimiliar Insulins?

Between 2011 and 2013, many insulin manufacturers will see several important insulin analogues coming off patent, and therefore will be available for many other companies to produce and market, with copies of current branded insulins named ‘biosimilar insulins’. Many medications for diabetes in the past, such as metaformin, once off patent have been easily reproduced,…

Read More